Basic Materials / Specialty ChemicalsBSE
$18.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $2.4M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$122M
P/E
6.8x
↓EV/EBITDA
7.5x
↓ROE
6.1%
↑Gross Margin
-164.6%
↓Debt/Equity
0.27
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-39.7%
FCF CAGR
—
FCF margin
-61.6%
FCF / Net income
-9.37x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $187.0M · net income $12.3M · FCF $-115.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $187.0M | $187.0M | $196.1M | $209.4M | $852.2M |
| Net Income | $12.3M | $12.3M | $13.9M | $3.6M | $2.4M |
| EBITDA | $19.7M | $19.7M | $17.9M | $5.8M | $4.3M |
| EPS | 2.26 | 2.26 | 2.04 | 0.53 | 0.35 |
| Gross Margin | -164.6% | -164.6% | 17.9% | 9.0% | 1.8% |
| Operating Margin | 8.6% | 8.6% | 9.1% | 2.7% | 0.4% |
| Net Margin | 6.6% | 6.6% | 7.1% | 1.7% | 0.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.27 | 0.27 | 0.14 | 0.18 | 0.19 |
| Current Ratio | 1.32 | 1.32 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-115.2M | $-115.2M | $4.9M | $2.4M | $-59.8M |
| Returns | |||||
| ROE | 6.1% | 6.1% | 18.5% | 5.9% | 4.1% |
| Valuation | |||||
| P/E | 6.84 | 6.84 | — | — | — |
| EV/EBITDA | 7.50 | 7.50 | — | — | — |
| P/B | 0.48 | 0.48 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | -4.6% | -4.6% | -6.4% | -75.4% | — |
| EPS Growth | 10.7% | 10.7% | 282.7% | 51.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-10.9%
EPS terminal req.
$1.60
Spread vs growth
21.7%
5Y implied EPS CAGR
-3.1%
EPS terminal req.
$1.93
Spread vs growth
13.8%
10Y implied EPS CAGR
3.3%
EPS terminal req.
$3.11
Spread vs growth
7.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-41.7%
Start / end P/E
15.1x → 8.0x
EPS bridge
2.04 → 2.26
Residual
-5.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.